456 related articles for article (PubMed ID: 26753790)
21. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
[TBL] [Abstract][Full Text] [Related]
22. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
[TBL] [Abstract][Full Text] [Related]
23. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
24. GnRH Transactivates Human AMH Receptor Gene via Egr1 and FOXO1 in Gonadotrope Cells.
Garrel G; Denoyelle C; L'Hôte D; Picard JY; Teixeira J; Kaiser UB; Laverrière JN; Cohen-Tannoudji J
Neuroendocrinology; 2019; 108(2):65-83. PubMed ID: 30368511
[TBL] [Abstract][Full Text] [Related]
25. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
Qi X; Pang Y; Qiao J
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
[TBL] [Abstract][Full Text] [Related]
26. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
27. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
[TBL] [Abstract][Full Text] [Related]
28. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
29. New insights into anti-Müllerian hormone role in the hypothalamic-pituitary-gonadal axis and neuroendocrine development.
Silva MSB; Giacobini P
Cell Mol Life Sci; 2021 Jan; 78(1):1-16. PubMed ID: 32564094
[TBL] [Abstract][Full Text] [Related]
30. Effect of anti-Müllerian hormone in hypothalamic Kiss-1- and GnRH-producing cell models.
Oride A; Kanasaki H; Tumurbaatar T; Tumurgan Z; Okada H; Kyo S
Gynecol Endocrinol; 2021 Sep; 37(9):841-847. PubMed ID: 34236272
[No Abstract] [Full Text] [Related]
31. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase expression targeted to gonadotropin-releasing hormone neurons inhibits luteinizing hormone pulses in transgenic rats.
Paruthiyil S; eL Majdoubi M; Conti M; Weiner RI
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17191-6. PubMed ID: 12482943
[TBL] [Abstract][Full Text] [Related]
33. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
[TBL] [Abstract][Full Text] [Related]
34. The role of Amh signaling in teleost fish--Multiple functions not restricted to the gonads.
Pfennig F; Standke A; Gutzeit HO
Gen Comp Endocrinol; 2015 Nov; 223():87-107. PubMed ID: 26428616
[TBL] [Abstract][Full Text] [Related]
35. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
36. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome.
McCartney CR; Campbell RE; Marshall JC; Moenter SM
J Neuroendocrinol; 2022 May; 34(5):e13093. PubMed ID: 35083794
[TBL] [Abstract][Full Text] [Related]
37. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
38. Activation of a Classic Hunger Circuit Slows Luteinizing Hormone Pulsatility.
Coutinho EA; Prescott M; Hessler S; Marshall CJ; Herbison AE; Campbell RE
Neuroendocrinology; 2020; 110(7-8):671-687. PubMed ID: 31630145
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
[TBL] [Abstract][Full Text] [Related]
40. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
